Tegan Smith

1.5k total citations · 1 hit paper
31 papers, 1.2k citations indexed

About

Tegan Smith is a scholar working on Rheumatology, Hematology and Reproductive Medicine. According to data from OpenAlex, Tegan Smith has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Rheumatology, 14 papers in Hematology and 9 papers in Reproductive Medicine. Recurrent topics in Tegan Smith's work include Rheumatoid Arthritis Research and Therapies (15 papers), Autoimmune and Inflammatory Disorders Research (14 papers) and Sperm and Testicular Function (9 papers). Tegan Smith is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (15 papers), Autoimmune and Inflammatory Disorders Research (14 papers) and Sperm and Testicular Function (9 papers). Tegan Smith collaborates with scholars based in Australia, United States and United Kingdom. Tegan Smith's co-authors include R. John Aitken, Geoffry N. De Iuliis, Haley Connaughton, Richard Bronson, Mark A. Baker, Benjamin J. Curry, Matthew D. Dun, Nicolas Da Silva, Nathan D. Smith and Tessa Lord and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Cell Science and Free Radical Biology and Medicine.

In The Last Decade

Tegan Smith

30 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oxidative stress and male reproductive health

2014 446 citations R. John Aitken, Tegan Smith et al. Asian Journal of Andrology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tegan Smith Australia	13	765	556	239	150	109	31	1.2k
Elizabeth G. Bromfield Australia	27	1.0k 1.3×	823 1.5×	681 2.8×	109 0.7×	238 2.2×	64	1.8k
G. Grizard France	20	802 1.0×	531 1.0×	364 1.5×	64 0.4×	119 1.1×	64	1.3k
Selva Beatriz Cigorraga Argentina	20	678 0.9×	317 0.6×	482 2.0×	41 0.3×	234 2.1×	36	1.3k
Zhao‐Yuan Hu China	22	654 0.9×	567 1.0×	545 2.3×	34 0.2×	231 2.1×	46	1.3k
Hossein Nikzad Iran	11	329 0.4×	208 0.4×	223 0.9×	85 0.6×	108 1.0×	19	671
Meng‐yun Mo United States	11	431 0.6×	191 0.3×	261 1.1×	80 0.5×	81 0.7×	11	792
Lara Tamburrino Italy	24	1.3k 1.6×	1.0k 1.8×	283 1.2×	76 0.5×	175 1.6×	49	1.6k
Diana Harkiss United Kingdom	12	1.8k 2.4×	1.5k 2.7×	281 1.2×	304 2.0×	258 2.4×	12	2.3k
Michela Galdieri Italy	20	767 1.0×	276 0.5×	579 2.4×	55 0.4×	294 2.7×	60	1.5k
Sara Marchiani Italy	28	1.4k 1.9×	1.1k 2.0×	429 1.8×	88 0.6×	245 2.2×	63	2.0k

Countries citing papers authored by Tegan Smith

Since Specialization

Citations

This map shows the geographic impact of Tegan Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tegan Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tegan Smith more than expected).

Fields of papers citing papers by Tegan Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tegan Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tegan Smith. The network helps show where Tegan Smith may publish in the future.

Co-authorship network of co-authors of Tegan Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Tegan Smith. A scholar is included among the top collaborators of Tegan Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tegan Smith. Tegan Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Youssef, Peter, Joanna Leadbetter, Belinda Butcher, et al.. (2025). Real-World Persistence and Effectiveness of Upadacitinib versus Other Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors in Australian Patients with Rheumatoid Arthritis. Rheumatology and Therapy. 12(1). 173–202. 3 indexed citations

Littlejohn, Geoffrey, Joanna Leadbetter, Belinda Butcher, et al.. (2024). Real-world evaluation of persistence, effectiveness and usage patterns of tofacitinib in treatment of psoriatic arthritis in Australia. Clinical Rheumatology. 43(5). 1579–1589. 2 indexed citations

Littlejohn, Geoffrey, Catherine O’Sullivan, Tegan Smith, et al.. (2024). Optimising patient outcomes: temporal trends in remission rates of rheumatoid arthritis patients in the Australian OPAL dataset between 2009 and 2022. Clinical Rheumatology. 43(6). 1823–1832. 1 indexed citations

Littlejohn, Geoffrey, Tamás Treuer, Kathryn Gibson, et al.. (2023). Real-world utilisation and switching between Janus kinase inhibitors in Australian patients with rheumatoid arthritis in the OPAL dataset. Clinical and Experimental Rheumatology. 42(9). 1763–1772. 2 indexed citations

Deakin, Claire T., Geoffrey Littlejohn, Hedley Griffiths, et al.. (2023). Comparative effectiveness of etanercept originator and biosimilar for treating rheumatoid arthritis: implications for cost‐savings. Internal Medicine Journal. 54(5). 795–801. 1 indexed citations

Littlejohn, Geoffrey, et al.. (2023). Burden of disease and real-world treatment patterns of patients with systemic lupus erythematosus in the Australian OPAL dataset. Clinical Rheumatology. 42(11). 2971–2980. 3 indexed citations

Littlejohn, Geoffrey, Tamás Treuer, Kathryn Gibson, et al.. (2023). Comparative Effectiveness of First‐Line Baricitinib in Patients With Rheumatoid Arthritis in the Australian OPAL Data Set. ACR Open Rheumatology. 5(7). 345–353. 2 indexed citations

Tymms, Kathleen, Catherine O’Sullivan, Tegan Smith, et al.. (2023). A novel electronic patient-reported outcome delivery system to implement health-related quality of life measures in routine clinical care: An analysis of 5 years of experience. Frontiers in Digital Health. 4. 1074931–1074931. 3 indexed citations

Donaldson, Andrew, et al.. (2021). Pedestrian Impact Analysis of Side-Swipe and Minor Overlap Conditions. SAE International Journal of Advances and Current Practices in Mobility. 3(4). 1585–1598. 3 indexed citations

10.

Tymms, Kathleen, Belinda Butcher, Tracey L. Sletten, et al.. (2021). Prevalence of sleep disturbance and the association between poor disease control in people with ankylosing spondylitis within the Australian clinical setting (ASLEEP study): a real-world observational study using the OPAL dataset. Clinical Rheumatology. 41(4). 1105–1114. 6 indexed citations

11.

Griffiths, Hedley, et al.. (2021). Persistence to Biologic Therapy Among Patients With Ankylosing Spondylitis: An Observational Study Using the OPAL Dataset. The Journal of Rheumatology. 49(2). 150–156. 4 indexed citations

12.

Bird, Paul, Geoffrey Littlejohn, Belinda Butcher, et al.. (2021). Real-world evaluation of effectiveness, persistence, and usage patterns of monotherapy and combination therapy tofacitinib in treatment of rheumatoid arthritis in Australia. Clinical Rheumatology. 41(1). 53–62. 12 indexed citations

13.

Bird, Paul, et al.. (2020). Real-world evaluation of effectiveness, persistence, and usage patterns of tofacitinib in treatment of rheumatoid arthritis in Australia. Clinical Rheumatology. 39(9). 2545–2551. 22 indexed citations

14.

Silva, Nicolas Da & Tegan Smith. (2015). Exploring the role of mononuclear phagocytes in the epididymis. Asian Journal of Andrology. 17(4). 591–591. 32 indexed citations

15.

Shum, Winnie, Tegan Smith, Virna Cortez‐Retamozo, et al.. (2014). Epithelial Basal Cells Are Distinct from Dendritic Cells and Macrophages in the Mouse Epididymis1. Biology of Reproduction. 90(5). 90–90. 59 indexed citations

16.

Smith, Tegan, Geoffry N. De Iuliis, Tessa Lord, & R. John Aitken. (2013). The senescence-accelerated mouse prone 8 as a model for oxidative stress and impaired DNA repair in the male germ line. Reproduction. 146(3). 253–262. 33 indexed citations

17.

Smith, Tegan, Mark A. Baker, Haley Connaughton, U.‐F. Habenicht, & R. John Aitken. (2013). Functional deletion of Txndc2 and Txndc3 increases the susceptibility of spermatozoa to age-related oxidative stress. Free Radical Biology and Medicine. 65. 872–881. 65 indexed citations

18.

Aitken, R. John, Richard Bronson, Tegan Smith, & Geoffry N. De Iuliis. (2013). The source and significance of DNA damage in human spermatozoa; a commentary on diagnostic strategies and straw man fallacies. Molecular Human Reproduction. 19(8). 475–485. 114 indexed citations

19.

Johnson, W. Thomas & Tegan Smith. (1994). Copper Deficiency Increases Cytochrome P450-Dependent 7-Ethoxyresorufin-O-deethylase Activity in Rat Small Intestine. Experimental Biology and Medicine. 207(3). 302–308. 5 indexed citations

20.

Wilcox, Christopher S., et al.. (1989). The Captopril Glomerular Filtration Rate Renogram in Renovascular Hypertension. Clinical Nuclear Medicine. 14(1). 1–7. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact